Functional analysis of the novel sequence variants within TBX5 gene promoter in patients with ventricular septal defects

2012 ◽  
Vol 160 (3) ◽  
pp. 237-238 ◽  
Author(s):  
Jiping Shan ◽  
Shuchao Pang ◽  
Yanli Qiao ◽  
Liming Ma ◽  
Haihua Wang ◽  
...  
Keyword(s):  
Functional Analysis ◽  
Gene Promoter ◽  
Sequence Variants ◽  
The Novel ◽  
Ventricular Septal Defects ◽  
Septal Defects ◽  
Tbx5 Gene

scholarly journals Novel and Functional DNA Sequence Variants within the GATA6 Gene Promoter in Ventricular Septal Defects

2014 ◽  
Vol 15 (7) ◽  
pp. 12677-12687 ◽  
Author(s):  
Chunyu Li ◽  
Xianke Li ◽  
Shuchao Pang ◽  
Wei Chen ◽  
Xianyun Qin ◽  
...  
Keyword(s):  
Dna Sequence ◽  
Gene Promoter ◽  
Sequence Variants ◽  
Ventricular Septal Defects ◽  
Septal Defects ◽  
Dna Sequence Variants ◽  
Functional Dna ◽  
Gata6 Gene

Novel and functional sequence variants within the TBX2 gene promoter in ventricular septal defects

Biochimie ◽  
2013 ◽  
Vol 95 (9) ◽  
pp. 1807-1809 ◽  
Author(s):  
Shuchao Pang ◽  
Yumei Liu ◽  
Zhongqing Zhao ◽  
Wenhui Huang ◽  
Dongfeng Chen ◽  
...  
Keyword(s):  
Gene Promoter ◽  
Sequence Variants ◽  
Ventricular Septal Defects ◽  
Functional Sequence ◽  
Septal Defects

Novel and functional DNA sequence variants within the GATA5 gene promoter in ventricular septal defects

2014 ◽  
Vol 10 (4) ◽  
pp. 348-353 ◽  
Author(s):  
Ji-Ping Shan ◽  
Xiao-Li Wang ◽  
Yuan-Gang Qiao ◽  
Hong-Xin Wan Yan ◽  
Wen-Hui Huang ◽  
...  
Keyword(s):  
Dna Sequence ◽  
Gene Promoter ◽  
Sequence Variants ◽  
Ventricular Septal Defects ◽  
Septal Defects ◽  
Dna Sequence Variants ◽  
Functional Dna

Genetic and Functional Analysis of the NKX2-5 Gene Promoter in Patients With Ventricular Septal Defects

2012 ◽  
Vol 33 (8) ◽  
pp. 1355-1361 ◽  
Author(s):  
Shuchao Pang ◽  
Jiping Shan ◽  
Yanli Qiao ◽  
Liming Ma ◽  
Xianyun Qin ◽  
...  
Keyword(s):  
Functional Analysis ◽  
Gene Promoter ◽  
Ventricular Septal Defects ◽  
Septal Defects

Genetic analysis of the SIRT1 gene promoter in ventricular septal defects

2012 ◽  
Vol 425 (4) ◽  
pp. 741-745 ◽  
Author(s):  
Jiping Shan ◽  
Shuchao Pang ◽  
Hongxin Wanyan ◽  
Wen Xie ◽  
Xianyun Qin ◽  
...  
Keyword(s):  
Genetic Analysis ◽  
Gene Promoter ◽  
Ventricular Septal Defects ◽  
Septal Defects ◽  
Sirt1 Gene

scholarly journals Percutaneous-perventricular device closure of ventricular septal defect: mid-term follow-up.

2020 ◽  
Author(s):  
Long Wang ◽  
Lin Xie ◽  
Weiqiang Ruan ◽  
Tao Li ◽  
Changping Gan ◽  
...  
Keyword(s):  
Ventricular Septal Defect ◽  
Septal Defect ◽  
Close Monitoring ◽  
The Novel ◽  
Ventricular Septal Defects ◽  
Device Closure ◽  
Residual Shunt ◽  
Septal Defects ◽  
Perventricular Device Closure

Abstract Background: This report presents updated data and mid-term follow-up information to a former study introducing the novel technique of percutaneous-perventricular device closure of doubly committed subarterial ventricular septal defect. Methods: Thirty-eight patients were added to the former series. There were 54 patients in total who had isolated doubly committed subarterial ventricular septal defects and underwent percutaneous-perventricular device closure. Closure outcomes and possible complications were measured in the hospital and during the 2.5-year follow-up. Results: Surgery was successful in 53 patients (98.1%). There was no death, residual shunt, new valve regurgitation or arrhythmia either perioperatively or during the entire follow-up period. Only one patient developed pericardial effusion and tamponade in the former series. The mean hospital stay was 3.2±0.6 days (range, 3.0 to 6.0 days), and only one unsuccessful case needed blood transfusion (1.9%). Conclusions: The percutaneous-perventricular device closure of isolated doubly committed subarterial ventricular septal defects appeared to be safe. Close monitoring for bleeding is essential postoperatively, especially in younger patients. This technique is generally safe with acceptable mid-term follow-up.

scholarly journals Percutaneous-perventricular device closure of ventricular septal defect: mid-term follow-up.

2020 ◽  
Author(s):  
Long Wang ◽  
Lin Xie ◽  
Weiqiang Ruan ◽  
Tao Li ◽  
Changping Gan ◽  
...  
Keyword(s):  
Ventricular Septal Defect ◽  
Septal Defect ◽  
Close Monitoring ◽  
The Novel ◽  
Ventricular Septal Defects ◽  
Device Closure ◽  
Residual Shunt ◽  
Septal Defects ◽  
Perventricular Device Closure

Abstract Background: This report presents updated data and mid-term follow-up information to a former study introducing the novel technique of percutaneous-perventricular device closure of doubly committed subarterial ventricular septal defect. Methods: Thirty-eight patients were added to the former series. There were 54 patients in total who had isolated doubly committed subarterial ventricular septal defects and underwent percutaneous-perventricular device closure. Closure outcomes and possible complications were measured in the hospital and during the 2.5-year follow-up. Results: Surgery was successful in 53 patients (98.1%). There was no death, residual shunt, new valve regurgitation or arrhythmia either perioperatively or during the entire follow-up period. Only one patient developed pericardial effusion and tamponade in the former series. The mean hospital stay was 3.2±0.6 days (range, 3.0 to 6.0 days), and only one unsuccessful case needed blood transfusion (1.9%). Conclusions: The percutaneous-perventricular device closure of isolated doubly committed subarterial ventricular septal defects appeared to be safe. Close monitoring for bleeding is essential postoperatively, especially in younger patients. This technique is generally safe with acceptable mid-term follow-up.

Genetic analysis of the TBX3 gene promoter in ventricular septal defects

Gene ◽  
2013 ◽  
Vol 512 (2) ◽  
pp. 185-188 ◽  
Author(s):  
Dongfeng Chen ◽  
Yanli Qiao ◽  
Haihong Meng ◽  
Shuchao Pang ◽  
Wenhui Huang ◽  
...  
Keyword(s):  
Genetic Analysis ◽  
Gene Promoter ◽  
Ventricular Septal Defects ◽  
Septal Defects

scholarly journals Genetic Analysis of the CITED2 Gene Promoter in Isolated and Sporadic Congenital Ventricular Septal Defects

2021 ◽  
Vol 35 (S1) ◽  
Author(s):  
Si‐Qiang Zheng ◽  
Huan‐Xin Chen ◽  
Xiao‐Cheng Liu ◽  
Qin Yang ◽  
Guo‐Wei He
Keyword(s):  
Genetic Analysis ◽  
Gene Promoter ◽  
Ventricular Septal Defects ◽  
Septal Defects
Sign in / Sign up

Export Citation Format

Share Document